Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-19
    E.g., 2018-09-19

Archive Search

1 results
4:53 PM, May 03, 2013  |  BC Extra | Top Story

Regeneron gains after 1Q13 results

targeting platelet derived growth factor (PDGF) for all indications including ophthalmology, and to antibodies targeting angiopoietin 2
ANG2 ; ANGPT2 ) for ophthalmology indications only. Sanofi will receive $10 million up front …
40 million in milestones for the PDGF antibodies and a $5 million milestone for the ANG2